Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Daily Record
Daily Record
Lifestyle
Nina Massey & Sophie Law

Parkinson's symptoms as brain scanners could help 'untreatable signs of disease'

Ultra-powerful brain scanners could offer hope for the treatment of previously-untreatable symptoms in Parkinson’s disease, a new study suggests.

Both Parkinson’s disease and a related disorder, progressive supranuclear palsy (PSP), are progressive brain diseases that not only affect movement but also damage motivation and cognition.

Cognition refers to the mental processes that take place in the brain, including thinking, attention, language, learning, memory and perception.

These symptoms can have a major impact on a patient’s outcome, affecting survival and general wellbeing, as well as the stress and costs for families.

To understand the causes of these cognitive symptoms, researchers at the University of Cambridge used a new ultra-high strength “7T” MRI scanner at the Wolfson Brain Imaging Centre.

They measured changes in the brains of people with Parkinson’s disease, PSP, or who were in good health.

The 7T refers to the strength of the magnetic field – most MRI scanners tend to be 3T or below.

Patients with Parkinson’s and PSP are often treated with drugs such as L-DOPA, which compensate for the severe loss of dopamine – a brain chemical that influences mood and feelings of reward and motivation.

But dopamine treatment does little for many of the non-motor symptoms, and scientists have started to look at noradrenaline, a chemical that plays a critical role in brain functions, including attention and arousal, thinking and motivation.

Professor James Rowe from the Department of Clinical Neurosciences at the University of Cambridge, who led the study, said: “Noradrenaline is very important for brain function.

Ultra-powerful brain scanners could offer hope for the treatment of previously-untreatable symptoms in Parkinson’s disease (Getty Images)

“All of our brain’s supply comes from a tiny region at the back of the brain called the locus coeruleus, which means ‘the blue spot’.

“It’s a bit like two short sticks of spaghetti half an inch long: it’s thin, it’s small, and it’s tucked away at the very base of the brain in the brain stem.”

Researchers wanted to know how they could examine this tiny region of the brain, as previous MRI scanners have not been powerful enough.

While most scanners can show structures at the level of detail of a grain of rice, 7T scanners, which have ultra-strong magnetic fields, can provide resolution at the size of a grain of sand.

This allowed the team to examine the locus coeruleus of patients and confirm that the greater the level of damage to this region, the more severe their symptoms of apathy and the worse they performed at cognitive tests.

Researchers suggest the findings offer the hope of new treatments for these symptoms.

A number of drugs that boost noradrenaline have already been through clinical trials for other conditions and have been shown to be safe and well tolerated, the experts say.

Professor Rowe and colleagues are now leading a clinical trial at Cambridge University Hospitals NHS Foundation Trust to see if these drugs alleviate symptoms in PSP.

Dr Rong Ye from the Department of Clinical Neurosciences at the University of Cambridge, the study’s joint first author, said: “Not every PSP or Parkinson’s patient is going to benefit from noradrenaline-boosting drugs.

“They’re more likely to benefit those people with damage to their locus coeruleus – and the greater the damage, the more benefit they’re likely to see.

“The ultra-powerful 7T scanner may help us identify those patients who we think will benefit the most.

“This will be important for the success of the clinical trial and, if the drugs are effective, will mean we know which patients to give the treatment to.

“In the long term, this will prove more cost-effective than giving noradrenaline boosters to patients who ultimately would see no benefit.”

The research was supported by Parkinson’s UK, the Cambridge Centre for Parkinson-Plus, and others across the world.

It is published in the journal Movement Disorders.

10 early symptoms of Parkinson's disease

1. Problems with your sleep

According to Parkinson's UK Scotland, sleep and night-time problems are common in Parkinson's.

People with Parkinson's are more likely to experience insomnia due to certain symptoms which can disrupt sleep. Very vivid dreams is a possible sleep issue.

These include tremor, stiffness, pain and restless leg syndrome. If sleep is affected, people may also feel tired and drowsy during the day.

2. Losing your sense of smell

Someone with Parkinson's may notice that their sense of smell may not be as strong as it was or has disappeared.

For example, someone may struggle to smell their favourite foods. Loss of smell can sometimes start years before other symptoms develop.

3. Small handwriting

Because of changes in the brain, people with Parkinson's can find that their movements become smaller and less forceful than before.

This can lead to someone's handwriting becoming smaller than it previously was or gradually getting smaller as they write.

4. Constipation and bladder problems

If you have Parkinson's, you may be more likely to have problems with your bladder or bowels.

Signs of an overactive bladder, such as needing to use the toilet immediately without warning, or needing to go frequently throughout the night, are the most common bladder symptoms of people with Parkinson's.

5. Depression

You may have depression if you are experiencing feelings of extreme sadness or a sense of emotional 'emptiness' for a long time.

It's more than a temporary feeling of sadness, unhappiness or frustration. In some cases, people with Parkinson's may experience depression months before they notice any other symptoms.

Depression can also be a symptom of 'non-motor fluctuations' – in other words, when the non-motor symptoms of Parkinson's can increase or fall depending on medication timing.

This happens when the effects of levodopa 'wear off' before the next dose is due.

6. Anxiety

People with Parkinson's may experience anxiety, including feelings of unease, such as worry or fear – particularly in the early stages of the condition.

Any concerns that someone has about living with a long-term condition may cause anxiety.

Common symptoms of anxiety include: a sense of dread, constant worry or difficulty concentrating, sweating, pounding or racing heart (palpitations), feeling breathless, dizziness or trembling.

7. Fatigue

Feelings of fatigue – tiredness that doesn't go away however much someone rests – affect up to half of people with Parkinson's.

You may feel quite fit and able one day and then too fatigued to do much the following day.

If you're working, for example, you may feel much more exhausted in the evenings than you used to, and you may not want to do anything else.

Fatigue in Parkinson's is thought to be caused by chemical changes in the brain. It may also be related to other symptoms or features of the condition, such as tremor, stiffness or feelings of stress.

Mental (cognitive) fatigue can be another symptom. Some people may find it hard to concentrate for a long time without a break.

Don't miss the latest news from around Scotland and beyond - sign up to our daily newsletter here

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.